Pharmacists can do more to bridge the safety gaps for people with learning disabilities People with learning disabilities are more likely to be taking multiple medicines, but labels are not designed with them in mind — it is time to pay more attention to this patient group’s needs.…
PSA writes to health secretary to ‘raise concerns’ over GPhC’s fitness-to-practise timeliness Duncan Rudkin, chief executive of the GPhC, said it was “an absolute priority” for it to resolve fitness-to-practise cases “in a timely way”.…
Hydrocortisone manufacturers to be fined almost £130m after tribunal upholds ruling The Competition and Markets Authority said NHS spending on hydrocortisone tablets rose from £0.5m per year to over £80m.…
GPhC facing biggest ever backlog of open fitness-to-practise cases at initial assessment stage Council papers said there were more than 700 open initial assessment fitness-to-practise cases.…
RPS says codeine linctus should be made a prescription-only medicine, in response to MHRA consultation The Royal Pharmaceutical Society says reclassification will make it easier to monitor codeine linctus use, because it will be recorded in GP systems.…
Decision to fine liothyronine supplier millions of pounds for price hikes upheld at tribunal Fines of £84.2m have been imposed on Advanz Pharma and two former owners after a tribunal upheld the Competition and Markets Authority’s judgement that they had breached competition law.…
Community pharmacy supervision does not mean overseeing ‘individual transactions’, pharmacy bodies determine The cross-sector group of seven pharmacy sector organisations says public, primary and secondary legislation should be updated to reflect its supervision recommendations.…
Government proposals to consider medicines reclassification should include moves to general sales list, says trade body The PAGB has said the current process of reclassification could be “streamlined” and “we need to act now” to ensure people have greater access to the medicines they need.…
Would UK approval of lecanemab be a game changer for people with Alzheimer’s disease? Experts are divided over whether lecanemab is a cost-effective intervention for Alzheimer’s disease, raising concerns that the NHS is not ready for it.…
MHRA consults on reclassifying codeine linctus as a prescription-only medicine The Commission on Human Medicines previously said that codeine linctus is being used as an ingredient of 'purple drank', an illegal recreational drink that has been popularised through social media and music.…